Skip to main content
H

Hin Sang Group (International) Holding Co. Ltd. — Investor Relations & Filings

Ticker · 6893 HKEX Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 6893

About Hin Sang Group (International) Holding Co. Ltd.

http://www.hinsanggroup.com

Hin Sang Group (International) Holding Co. Ltd. operates as an investment holding company focused on the healthcare sector. Its core business activities encompass the development, manufacturing, marketing, sale, and distribution of a diverse range of products, including specialized children's healthcare items, traditional Chinese medicines, personal care products, and general household goods. The company primarily serves markets in Hong Kong and Mainland China.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-04 English
List of Directors and their Roles and Functions
Board/Management Information Classification · 1% confidence The document is an announcement by Hin Sang Group listing the members of its Board of Directors, their roles, and committee memberships, effective 20 April 2026. This clearly constitutes a Board/Management Information announcement regarding changes in the company’s board structure. It does not present financials or attach a report, but rather communicates governance appointments.
2026-04-20 English
(1) APPOINTMENT OF CHIEF EXECUTIVE OFFICER; (2) APPOINTMENT OF EXECUTIVE DIRECTOR; AND (3) CHANGE OF AUTHORISED REPRESENTATIVE
Board/Management Information Classification · 1% confidence The document is an official announcement by a listed company regarding appointments of a new Chief Executive Officer, an Executive Director, and a change of authorised representative. This fits squarely into Board/Management Information, as it relates to changes in senior management and board roles. Therefore, the correct classification is MANG.
2026-04-20 English
(1) INSIDE INFORMATION, (2) SUSPENSION OF DUTIES AND POWERS OF THE CHAIRMAN, THE CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR, (3) APPOINTMENT OF ACTING CHAIRMAN; AND (4) APPOINTMENT OF AUTHORISED
Board/Management Information Classification · 1% confidence The document is an announcement disclosing the suspension of duties of the chairman/CEO, the appointment of an acting chairperson, and the appointment of an authorised representative and process agent. These are changes in the company’s board and senior management roles. This fits the definition of Board/Management Information (MANG).
2026-04-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings Classification · 1% confidence The document is a Hong Kong Exchange (HKEX) Chapter 19B ‘‘FF301’’ Monthly Return for Equity Issuers detailing movements in authorised share capital, issued shares, treasury shares, share options, and public float confirmations for the month ended 31 March 2026. It is a periodic regulatory compliance return rather than an AGM document, earnings release, annual or interim report, or specific corporate action announcement (e.g., M&A, dividend notice). It does not represent a standalone audit report, management discussion, or capital raising update. As it is a routine regulatory listing return with no other specific category match, it falls under the general “Regulatory Filings” category (RNS) as the fallback for miscellaneous compliance submissions.
2026-04-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and treasury shares. Since it is a recurring regulatory filing regarding share capital and securities movements that does not fit into specific categories like 'Share Issue' (which usually implies a specific event) or 'Transaction in Own Shares' (which is for specific buybacks), it is best classified as a Regulatory Filing (RNS).
2026-03-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.